Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes
Open Access
- 24 August 2018
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 16 (1) , 234
Abstract
Hyaluronan (HA), a major component of the extracellular matrix, has been proven to play a crucial role in tumor progression. However, it remains unknown whether HA exerts any effects in myelodysplastic syndromes (MDS). A total of 82 patients with MDS and 28 healthy donors were investigated in this study. We firstly examined the bone marrow (BM) serum levels of HA in MDS by radioimmunoassay. Then we determined HA production and hyaluronan synthase (HAS) gene expression in BM mesenchymal stromal cells (MSC) and mononuclear cells derived from MDS patients. Finally, we investigated the effects of HA on osteogenic differentiation of MSC. The BM serum levels of HA was increased in higher-risk MDS patients compared to normal controls. Meanwhile, patients with high BM serum HA levels had significantly shorter median survival than those with low HA levels. Moreover, the HA levels secreted by MSC was elevated in MDS, especially in higher-risk MDS. In addition, HAS-2 mRNA expression was also up-regulated in higher-risk MDS-MSC. Furthermore, we found that MSC derived from MDS patients with high BM serum HA levels had better osteogenic differentiation potential. Moreover, MSC cultured in HA-coated surface presented enhanced osteogenic differentiation ability. Our results show that elevated levels of BM serum HA are related to adverse clinical outcome in MDS. Better osteogenic differentiation of MSC induced by HA may be implicated in the pathogenesis of MDS.Keywords
Funding Information
- National Nature Science Foundation of China (NNSFC81770121, NNSFC81600095, NNSFC81570108)
This publication has 35 references indexed in Scilit:
- Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchymal stem cellsJournal of Tissue Engineering and Regenerative Medicine, 2012
- Hyaluronan Regulates Cell Behavior: A Potential Niche Matrix for Stem CellsBiochemistry Research International, 2012
- TGF-β and BMP Signaling in Osteoblast Differentiation and Bone FormationInternational Journal of Biological Sciences, 2012
- Controlling the adhesion and differentiation of mesenchymal stem cells using hyaluronic acid-based, doubly crosslinked networksBiomaterials, 2011
- Hyaluronan and mesenchymal stem cells: from germ layer to cartilage and boneFrontiers in Bioscience-Landmark, 2011
- Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4Journal of Cell Science, 2007
- Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in myelodysplastic syndromesLeukemia, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrowBlood, 2004
- Identification of the Hyaluronan Receptor for Endocytosis (HARE)Journal of Biological Chemistry, 2000